International Drug Safety Monitoring

In the 1960s, following the Thalidomide Disaster, the World Health Organization (WHO) initiated the development of an international drug safety monitoring programme. The objectives of this WHO programme are to improve the quality and safety of pharmaceuticals, and to support public health programmes...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: A. S. Kazakov, E. V. Shubnikova, M. A. Darmostukova, I. I. Snegireva, G. V. Kutekhova, K. E. Zatolochina, N. Yu. Velts, D. A. Kaperko, Yu. V. Olefir
Formato: Artigo
Idioma:Russo
Publicado em: Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation 2019-09-01
Colecção:Безопасность и риск фармакотерапии
Assuntos:
drug safety monitoring
adverse drug reactions
pharmacovigilance
world health organization
vigibase
Acesso em linha:https://www.risksafety.ru/jour/article/view/151
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados